Prospective multicenter evaluation of 18F-FDG PET/CT and strain for early cardiotoxicity detection in lymphoma patients [0.03%]
前瞻性多中心研究评估18F-FDG PET/CT和应变在淋巴瘤患者早期心毒性的检测中的应用
Mônica de Moraes Chaves Becker,Roberto de Oliveira Buril,Mauro Rogério de Barros Wanderley Júnior et al.
Mônica de Moraes Chaves Becker et al.
Background: Anthracycline-induced cardiotoxicity (CTX) requires close monitoring in lymphoma patients. Increased myocardial uptake of fluorine-18-fluorodeoxyglucose (18F-FDG) via positron emission tomography combined with...
Bridging gaps in AI-driven cardio-oncology: global advances and Middle East perspectives [0.03%]
人工智能驱动的心脏肿瘤学中的缺口：全球进展和中东展望
Arif Albulushi,Hatem Al-Farhan
Arif Albulushi
Background: Cardiotoxicity remains a critical barrier to effective cancer treatment, contributing significantly to morbidity and mortality in cancer survivors. Recent advancements (2020-2025) highlight artificial intellig...
Clinical characteristics and treatment outcomes of primary cardiac sarcomas: a retrospective analysis [0.03%]
原发性心脏肉瘤的临床特征及治疗结局分析：一项回顾性研究
Jun Cao,Zhichao Tan,Enyu Yang et al.
Jun Cao et al.
Objectives: Primary cardiac sarcomas (PCSs) are uncommon malignant tumors with a poor prognosis. This study aims to present the clinical characteristics and treatment outcomes for PCS observed in our centers. ...
CPX-351 vs. conventional chemotherapy cardiotoxicity in high-risk AML: a post hoc phase III trial analysis [0.03%]
高危AML患者采用CPX-351与常规化疗的后设分析的III期临床试验的心脏毒性
Joshua D Mitchell,Michael Pfeiffer,John Boehmer et al.
Joshua D Mitchell et al.
Background: CPX-351, a dual-drug liposomal encapsulation of daunorubicin and cytarabine in a synergistic 1:5 molar ratio, has demonstrated significantly improved overall survival in acute myeloid leukemia (AML) compared w...
Electrocardiographic manifestations and targeted management of cardiac complications in cardiac-involved DLBCL: a retrospective case series [0.03%]
心脏受累的DLBCL患者的心电图表现及心脏并发症的目标管理：病例系列回顾研究
Jen-Yu Chuang,Kuan-Ting Chen,Johnson Lin et al.
Jen-Yu Chuang et al.
Background: Cardiac involvement in diffuse large B-cell lymphoma (DLBCL) is rare but often complicated by life-threatening arrhythmias, conduction disturbances, and heart failure. Electrocardiography (ECG) is essential fo...
Real-world analysis of cardiovascular adverse events and risk factors after immune checkpoint inhibitor therapy [0.03%]
免疫检查点抑制剂治疗后心血管不良事件和风险因素的现实世界分析
Yanfei Wang,Shu Niu,Bently P Doonan et al.
Yanfei Wang et al.
Background: Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, offering significant survival benefits across diverse malignancies. However, growing evidence suggest an increased occurrence of cardiova...
Sally Badaan,Adi Abbass,Svetlana Tov et al.
Sally Badaan et al.
Immune checkpoint inhibitors (ICIs) have significantly advanced cancer therapy. However, these therapies can disrupt immune self-tolerance, leading to immune-related adverse events, among which immune checkpoint inhibitor-related myocarditi...
Breast cancer progression in the presence of treated and untreated left ventricular dysfunction [0.03%]
治疗和未治疗的左心室功能不全情况下乳腺癌的发展进展
Celine Civati,B K Goovaerts,S Van Laere et al.
Celine Civati et al.
Background: Recent studies have shown that heart failure (HF) and left ventricular (LV) dysfunction are associated with enhanced tumor growth. However, whether treating LV dysfunction mitigates its impact on cancer progre...
Association between cardiac radiation dose and coronary artery calcification progression in breast cancer patients after radiotherapy: the modifying role of concomitant systemic inflammation (BACCARAT study) [0.03%]
乳腺癌患者放疗后心脏辐射剂量与冠脉钙化进展的关系：同期全身性炎症的调节作用（BACCARAT研究）
Médéa Locquet,Georges Tarlet,David Broggio et al.
Médéa Locquet et al.
Radiation-induced cardiotoxicity remains a significant concern in breast cancer (BC) patients treated with radiotherapy (RT), with both cardiac radiation exposure and systemic inflammation emerging as key contributors to early cardiovascula...
Risk of myocardial infarction following capecitabine treatment in patients with gastrointestinal cancer - a nationwide registry-based study [0.03%]
卡培他滨治疗对胃肠肿瘤患者心肌梗死风险的影响——一项基于全国登记数据的研究
Jan Walter Dhillon Shanmuganathan,Kristian Kragholm,Harman Yonis et al.
Jan Walter Dhillon Shanmuganathan et al.
Background: Myocardial infarction (MI) is an adverse event potentially associated with capecitabine treatment, potentially impacting the continuation of cancer therapy. However, data on its incidence remain limited. ...